<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In investigating potent <z:chebi fb="199" ids="26708">sodium</z:chebi> (<z:chebi fb="0" ids="29101">Na(+)</z:chebi>) channel blockers for the treatment of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, we synthesized a novel series of 3-amino-1-(5-indanyloxy)-2-propanol derivatives and evaluated their inhibitory effects on neuronal <z:chebi fb="0" ids="29101">Na(+)</z:chebi> channels </plain></SENT>
<SENT sid="1" pm="."><plain>The 3-amino-1-(5-indanyloxy)-2-propanol derivatives exhibited potent blocking activity for <z:chebi fb="0" ids="29101">Na(+)</z:chebi> channels and a significantly low affinity for <z:chebi fb="40" ids="18243">dopamine</z:chebi> D(2) receptors, which demonstrates a minimal clinical risk for extrapyramidal side effects </plain></SENT>
<SENT sid="2" pm="."><plain>In particular, compound 4b, a 3-amino-1-(5-indanyloxy)-2-propanol derivative bearing a <z:chebi fb="0" ids="36622">benzimidazole</z:chebi> moiety, showed desirable neuroprotective activity in a rat transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, compound 4b displayed a high binding affinity for neurotoxin receptor site 2 of the <z:chebi fb="0" ids="29101">Na(+)</z:chebi> channels, which suggests that 4b would act as a use-dependent <z:chebi fb="0" ids="29101">Na(+)</z:chebi> channel blocker in sustained depolarization during <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>